Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diane Solomon

Showing results (21-30 of 95) with videos related to

Pageof 10
Sort By:
Cancer|November 5, 2008
Predicting the effect of successful human papillomavirus vaccination on existing cervical cancer prevention programs in the United StatesPhilip E Castle, Diane Solomon, Debbie Saslow, et al.
Cancer|April 12, 2005
Does the interval between papanicolaou tests influence the quality of cytology?Jose Jeronimo, Michelle J Khan, Mark Schiffman, et al.
Cancer|September 5, 2006
Comparison of human papillomavirus distribution in cytologic subgroups of low-grade squamous intraepithelial lesionRosemary E Zuna, Sophia S Wang, Mark Schiffman, et al.
American Journal of Clinical Pathology|February 6, 2007
The expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well-validated assaysMark H Stoler, Philip E Castle, Diane Solomon, et al.
Obstetrics and Gynecology|June 2, 2007
Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significanceMahboobeh Safaeian, Diane Solomon, Sholom Wacholder, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 15, 2005
Evaluating the risk of cervical precancer with a combination of cytologic, virologic, and visual methodsSophia S Wang, Joan L Walker, Mark Schiffman, et al.
Journal of the National Cancer Institute|July 21, 2005
Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalitiesPhilip E Castle, Diane Solomon, Mark Schiffman, et al.
Obstetrics and Gynecology|December 24, 2008
Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2Philip E Castle, Mark Schiffman, Cosette M Wheeler, et al.
American Journal of Obstetrics and Gynecology|August 8, 2006
Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS)Joan L Walker, Sophia S Wang, Mark Schiffman, et al.
American Journal of Clinical Pathology|April 19, 2007
The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS reportPhilip E Castle, Mark H Stoler, Diane Solomon, et al.
Pageof 10

Showing results (21-30 of 95) with videos related to

Sort By:
Pageof 10
Cancer|November 5, 2008
Predicting the effect of successful human papillomavirus vaccination on existing cervical cancer prevention programs in the United StatesPhilip E Castle, Diane Solomon, Debbie Saslow, et al.
Cancer|April 12, 2005
Does the interval between papanicolaou tests influence the quality of cytology?Jose Jeronimo, Michelle J Khan, Mark Schiffman, et al.
Cancer|September 5, 2006
Comparison of human papillomavirus distribution in cytologic subgroups of low-grade squamous intraepithelial lesionRosemary E Zuna, Sophia S Wang, Mark Schiffman, et al.
American Journal of Clinical Pathology|February 6, 2007
The expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well-validated assaysMark H Stoler, Philip E Castle, Diane Solomon, et al.
Obstetrics and Gynecology|June 2, 2007
Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significanceMahboobeh Safaeian, Diane Solomon, Sholom Wacholder, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 15, 2005
Evaluating the risk of cervical precancer with a combination of cytologic, virologic, and visual methodsSophia S Wang, Joan L Walker, Mark Schiffman, et al.
Journal of the National Cancer Institute|July 21, 2005
Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalitiesPhilip E Castle, Diane Solomon, Mark Schiffman, et al.
Obstetrics and Gynecology|December 24, 2008
Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2Philip E Castle, Mark Schiffman, Cosette M Wheeler, et al.
American Journal of Obstetrics and Gynecology|August 8, 2006
Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS)Joan L Walker, Sophia S Wang, Mark Schiffman, et al.
American Journal of Clinical Pathology|April 19, 2007
The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS reportPhilip E Castle, Mark H Stoler, Diane Solomon, et al.
Pageof 10